RxDoctor Payments Data

Erica Jenkins

Gerontology · Los Angeles, CANPI 1174865729

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.8% of the total across 198 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 43 manufacturers reported payments, led by Boston Scientific at 31.9% of the total. Among gerontology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,951in general payments, 2019–2025

Across 198 payments — averaging $35.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • SPR Therapeutics, Inc$681
  • AbbVie$652
  • Lundbeck LLC$473
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$188
  • E.r. Squibb & Sons, L.L.C.$183
  • plus $3K from 37 others

What the payments were for

  • Travel & lodging$5017%
  • Food & beverage$6,45093%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,951 in reported general payments places this provider in the 90th percentile of 348 gerontology providers in California.

See all gerontology providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levorphanol Tartrate13$42,661
Xtampza ErOxycodone Myristate37$20,984
LinzessLinaclotide12$5,864
Celecoxib21$1,105
Duloxetine Hcl46$1,085
Oxycodone Hcl33$613
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen42$420
Morphine Sulfate ErMorphine Sulfate16$377
Gabapentin47$303
Pregabalin32$253
Bupropion Hcl14$220
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$203
Trazodone Hcl12$193
Topiramate30$191
Hydromorphone Hcl25$112

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Virtus Pharmaceuticals LLCLevorphanol Tartrate$150$42,66113 claims
Collegium Pharmaceutical, Inc.Xtampza Er$114$20,98437 claims
AbbVieLinzess$652$5,86412 claims
Almatica Pharma LLCSertraline Hcl$61$1312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 348 gerontology providers in California.

Other gerontology in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →